Navigation Links
Federal grant funds research on novel HIV therapy

of agents called neurokinin-1 receptor antagonists, may represent a new type of anti-HIV therapy, due to its ability to block HIV replication. The new program project grant will allow researchers to explore the potential of neurokinin-1 receptor (NK-1R) antagonists in a variety of ways.

In addition to studying direct antiviral action, the researchers will also look for effects on behavior. Because NK-1R antagonists are known to have antidepressant properties, any evidence of reduced anxiety-related behavior in animals may suggest potential important benefits for human HIV patients as well.

The grant includes four separate projects. Projects 1 and 2, led by virologist Wen-Zhe Ho, M.D., of Children's Hospital, and Dr. Douglas, respectively, aim to better understand the underlying mechanisms behind anti-HIV activity of NK-1R antagonists. The basic science research will particularly examine how these agents affect HIV-infected immune cells and how they also might protect the brain. "We know that substance P plays an important role in both the immune system and the central nervous system," said Dr. Douglas, "and we are testing the hypothesis that interfering with substance P receptors may reduce neurological injury from HIV infection."

Project 3, led by Andrew A. Lackner, Ph.D., D.V.M., director of the Tulane National Primate Research Center, will test whether NK-1R antagonists are safe in animals infected with simian immunodeficiency virus (SIV), which is analogous to HIV. This study aims to provide proof of concept for human trials under Project 4.

Project 4, led by Pablo Tebas, M.D., of the Department of Medicine at the University of Pennsylvania Medical School, will be a phase 1 (safety) trial of the NK-1R antagonist aprepitant (trade name Emend) in adults with HIV infection. Aprepitant is currently used to control nausea caused by chemotherapy; this project will determine whether the antagonist may also attack HIV infection in pati
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2 3

Related biology news :

1. Federal testing for mad cow disease a failure, law review editor says
2. Researcher gets NSF grant to create mutant maize lines
3. MSU researchers receive $4 million grant to uncover gene functions
4. Virulizin granted orphan drug status in Europe
5. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
6. Asian immigrants in NYC not receiving HIV education at religious institutions
7. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
8. Scientists win grants to develop $1,000 genome sequencing technology
9. In presence of fragrant cleaning products, air purifiers that emit ozone can dirty the air
10. W.M. Keck Foundation funds study of friendly microbes
11. WHO suspends Marburg work, appeals for new funds
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Federal grant funds research novel HIV therapy

(Date:10/1/2014)... form of non-genetic inheritance, showing for the first time ... in flies at least., This confronting idea, known ... was discredited in the early 20th Century with the ... scientists Dr Angela Crean, Professor Russell Bonduriansky and Dr ... studied their offspring., They found that the size of ...
(Date:10/1/2014)... researchers hope to take a healthy salad up a ... of breast cancer in leafy greens. , "In the ... either by eating the salad or making a pill ... of biomedical engineering at Case Western Reserve School of ... G. Komen breast cancer organization is funding the research ...
(Date:10/1/2014)... October 1, 2014 ... der Biowissenschaften   Die Biowissenschaften erlebten ... Gehen zahlreicher Detektionstechnologien. Einige davon sind Senkrechtstarter ... Die Photonen-Upconversion ist eine neuartige Detektionstechnologie, die ... Begeisterung aufgenommen wurde. Jetzt ist diese Technologie ...
Breaking Biology News(10 mins):Semen secrets: How a previous sexual partner can influence another male's offspring 2Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Innovative Verwendungslösung für die Photonen-Upconversion 2Innovative Verwendungslösung für die Photonen-Upconversion 3
... Anthony D. Rosato, PhD, a professor in the department ... has received a Fulbright Senior Research Award ... particles at the University of Salerno, in Fisciano, Italy. ... Rosato recently presented an invited seminar there entitled "Microstructure ...
... The American Society for Biochemistry and Molecular Biology ... nonprofit,s annual awards. Another winner was announced earlier this ... society,s annual meeting April 9-13 in Washington, D.C., are ... Medical Institute investigator Axel T. Brunger won the inaugural ...
... ones making exciting scientific discoveries these days. Two middle ... who are reporting the first glimpse of the innermost ... certain antibiotics and anti-cancer agents so that those substances ... journal Biochemistry . The student co-authors of the ...
Cached Biology News:NJIT professor receives Fulbright to study at University of Salerno 2American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 2American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 3American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists 4
(Date:10/1/2014)... , Cambridge Semantics, the leading provider of Smart ... announced its participation in the 2014 Big Data Leaders ... provide semantic linkage and meaning to Big Data to ... diverse data. Ben Szekely, vice president and founding engineer ... sciences data lake” and an approach for collecting and ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 METTLER TOLEDO’s ... and precision balances as well as a ... in balance performance, the new SmartPan™ weighing pan delivers ... fume cupboard. On all balances, ergonomic design details mean ... strains from working for long periods in front of ...
(Date:10/1/2014)...  Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced ... II Small Business Innovation Research Grant (SBIR) valued ... Institute of Allergy and Infectious Diseases (NIAID) of ... the development of the Company,s aerosolized KL 4 ... acute and chronic/late-phase radiation-induced lung injury. The company ...
(Date:10/1/2014)... 1, 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and sale of high pressure-based sample preparation systems to ... been invited to present at the 2 nd ... , Poland.  The Conference will take place at the ... Richard T. Schumacher , President and CEO of PBI, ...
Breaking Biology Technology:Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 3Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 2Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 4
... Elsevier, the world-leading publisher of scientific, technical ... Hybrid Materials 2009: The First International Conference on ... in Tours, France, 15-19 March 2009. , ... annual growth in published papers in recent years ...
... 6 Dendreon Corporation,(Nasdaq: DNDN ) will release its fourth ... a conference call at,8:00 a.m. PT; 11:00 a.m. ET to review ... the discussion may be,obtained as follows:, Time: ... Date: March 13, 2008 Dial-in: ...
... Wyeth (NYSE: WYE ),confirmed today that it will appeal ... the U.S. District Court, Eastern District of,Arkansas, beginning with post-trial ... for this award or for the earlier,compensatory damage award. We ... case if necessary. We are confident in,our position on appeal," ...
Cached Biology Technology:Hybrid materials: Exciting interdisciplinary field offering future solutions for industry 2-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET- 2Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts 2Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts 3
...
Antibody Diluent for IHC 125 ml...
Sold individually or included in the MasterAmp™ PCR Optimization Kit without ammonium sulfate. Includes dNTPs, buffer, and varying amounts of MgCl2 and the MasterAmp™ PCR Enhancer (with be...
QPRT Antibody...
Biology Products: